A deleveraging target that does not close on organic cash flow implies an unannounced asset sale

Claim

A leverage target plus a date is a testable arithmetic statement, not a commitment. Test it.

required paydown = net debt − (target multiple × forecast EBITDA) years to close = required paydown ÷ (FCF − dividends − any other committed uses)

If years to close exceeds the promised timeline, something not in the guidance has to happen, and there are only three candidates: sell assets, issue equity, or cut the dividend. Naming which one before the company does is the whole value of the check.

Evidence — FIS, 2026-08-06

Input	Value
Net debt (Q1 2026, post-Issuer-Solutions)	$20.30B
Management gross leverage	3.6x
Stated target	2.8x by end-2027
FY26 adjusted EBITDA (implied by 41.5% Q2 margin on $13.65B revenue)	~$5.6B
Required net debt	~$15.7B
Required paydown	$4.6B
FY26 free cash flow (guided, raised)	$2.15–2.25B
Less dividends	−$0.91B
Available per year	$1.29B
Years to close at flat EBITDA	3.6 years
Years to close crediting 5% organic growth + $150M synergies by 2028	2.3 years

Management promised end-2027 — roughly 1.5 years. The gap is real under every assumption.

Two weeks earlier the same company announced it was "reviewing a possible sale of some parts of its capital markets business." The arithmetic predicted the announcement, and it also prices it: FIS is not shopping Capital Markets opportunistically, it is shopping it because the 2027 buyback resumption depends on the proceeds.

Why it changes the verdict rather than just the model

• It converts a stated plan into a conditional one. "Buybacks resume in 2027" becomes "buybacks resume in 2027 if the asset sale clears at a good price." Any thesis resting on the re-rating that follows deleveraging inherits that condition.
• It tells you the seller is not negotiating from strength. A divestiture that the deleveraging plan requires is a divestiture the buyer knows you need. Expect a weak price, stranded costs, and dis-synergies — FIS management said as much on the call ("products are highly integrated, so divestitures may involve stranded costs and leakage").
• It identifies the real break trigger. Not "leverage stays high" but "the asset sale is announced below expectations, or not at all."
• It is the mirror of the paused-buyback problem. The same companies that fail this test have usually already suspended repurchases, which removes the per-share tailwind for the duration. Check both together — they compound.

How to apply

1. Run the four-line arithmetic on any name that states a leverage target with a date. It needs net debt, the target, forecast EBITDA, FCF, and the dividend — all of which are in the guidance.
2. Use the company's own EBITDA definition so the answer is comparable to their multiple. Cross-check that their stated multiple reconciles; if it does not, the target is being measured against a number you cannot see.
3. Subtract the dividend. The single most common error is computing paydown capacity from gross FCF. A dividend-paying deleverager has far less room than it looks.
4. When the gap exists, ask which of the three fillers it is, and write the answer down as a named risk. Then treat any related "portfolio review" language as confirmation, not news.
5. Falsifier: a company that closes the gap purely through EBITDA growth. Possible, but it requires growth far above what a levered mature business usually guides — check whether the implied growth rate is one they have ever delivered.

Related

[[pattern-buyback-manufactured-eps-screens-as-growth]] — the same lens on the other side: that note covers buybacks flattering EPS, this one covers what happens when they stop · [[principle-primary-source-beats-vendor]] — the inputs come from the guidance table, not a vendor's leverage field.

History

• 2026-08-06 — derived during /analyze FIS. The check produced the report's second-largest risk and explained a corporate action (the Capital Markets sale process) that the press release presented as unrelated strategy.